China’s Nanjing King-Friend Takes Control Of US Injectables Specialist Meitheal

 
• By Dave Wallace

China’s Nanjing King-Friend Biochemical Pharmaceutical has taken a majority stake in US generic injectables specialist Meitheal Pharmaceuticals.

PieChart_Figures
Nanjing King-Friend Has Taken A Majority Share Of Meitheal • Source: Shutterstock

More from Deals

More from Business